Large randomized clinical trials (RCTs) have demonstrated their significant cardiovascular and renal benefits in individuals with type 2 diabetes [3, 4]
J., Wichmann, O., Utz, M., Andre, T., Petsalaki, E., Minguez, P., et al
Gastroesophageal reflux disease and its management in patients on semaglutide therapy
We assess deeper contributors to dysfunction, such as inflammation, hormonal imbalances, or nutrient deficiencies that can affect recovery and joint stability
Glucagon-like peptide-1 receptor agonists (GLP-1s) mimic the actions of a natural hormone that helps control blood sugar and appetite
They do not suit human use, and trained staff follow strict laboratory safety rules at all times